Biohaven Pharmaceutical Holding Co Ltd Earnings

The next earnings date for Biohaven Pharmaceutical Holding Co Ltd is March 19, 2026.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Biohaven Pharmaceutical Holding Co Ltd Earnings

Report Date	Estimated Earnings Per Share
05/08/2026	$-1.04
03/19/2026	$-1.18

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Biohaven Pharmaceutical Holding Co Ltd Earnings: Historical

Report Date	Before/After Market	Earnings Per Share	Surprise %
08/08/2025	---	$0	100.00%
08/04/2025	---	$0	100.00%
03/03/2025	---	$-1.71	-16.23%
11/13/2024	---	$-1.74	-12.21%
08/09/2024	---	$-3.50	-106.15%
05/09/2024	After Market	$-2.20	-40.13%
02/29/2024	After Market	$-1.81	-28.37%
11/14/2023	After Market	$-1.50	-11.94%
07/31/2023	Before Market	$-1.32	-9.09%
05/12/2023	After Market	$-1.03	26.95%
03/23/2023	After Market	$-3.32	-172.13%
11/09/2022	Before Market	$-1.75	25.21%
08/05/2022	Before Market	$-6.21	-140.70%
05/10/2022	Before Market	$-2.97	-17.39%
02/25/2022	Before Market	$-3.01	-47.55%
11/09/2021	Before Market	$-2.63	-9.58%
08/09/2021	Before Market	$-3.23	-18.75%
05/10/2021	Before Market	$-4.21	-49.29%
03/01/2021	Before Market	$-3.62	-21.89%
11/09/2020	Before Market	$-3.27	-13.15%
08/10/2020	Before Market	$-3.08	-18.01%
05/07/2020	After Market	$-3.07	-31.20%
02/25/2020	After Market	$-2.85	-52.41%
11/01/2019	After Market	$-2.04	-29.94%
08/08/2019	After Market	$-4.67	-143.23%
05/07/2019	Before Market	$-1.41	4.73%
02/28/2019	After Market	$-1.34	-10.74%
11/13/2018	After Market	$-1.53	-42.99%
08/14/2018	After Market	$-1.01	14.41%
05/15/2018	After Market	$-2.32	-103.51%
03/06/2018	After Market	$-0.75	37.50%
11/14/2017	After Market	$-1.19	-8.18%
08/14/2017	Before Market	$-1.78	-191.80%
06/15/2017	After Market	$-1.74	-120.25%
03/01/2017	---	$0	---
01/02/1991	---	$-4.67	---

More About Biohaven Pharmaceutical Holding Co Ltd

Website

https://www.biohaven.com

Country

USA

Full Time Employees

256

Biohaven Ltd. discovers, develops, and commercializes therapies for immunology, neuroscience, and oncology worldwide. The company develops troriluzole, which is in Phase 3 trial for the treatment of neurological and neuropsychiatric illnesses; taldefgrobep alfa, which is in Phase 3 clinical trial for the treatment of spinal muscular atrophy and obesity; BHV-7000, a candidate in Phase 3 clinical trial for the treatment of focal and generalized epilepsy, and major depressive disorder; BHV-2100 that is in Phase 2 clinical trial for the treatment of migraines and pain disorders; BHV-1510, which is in Phase ½ trial that targets advanced or metastatic epithelial tumors; and BHV-8000, a product candidate that completed Phase 1 clinical trial for the treatment of Alzheimer's and Parkinson's disease, and multiple sclerosis, as well as prevention of amyloid-related imaging abnormalities. It is also developing BHV-1300, which in Phase 1 clinical trial to treat Graves' disease and rheumatoid arthritis; BHV-1400 that is in Phase 1 trial for IgA nephropathy; BHV-1100, which is in Phase 1 trial for multiple myeloma patients; BHV-1600, which is in Phase 1 trial for the treatment of peripartum cardiomyopathy; BHV-1310 that is in preclinical trial for the treatment of generalized myasthenia gravis and other acute exacerbations or flares; BHV-1530, which is in preclinical trial to treat urothelial cancer; BHV-1500 that is in preclinical trial for Hodgkin's lymphoma; and BHV-5500 that blocks glutamate signaling mediated by post-synaptic NMDA receptors. The company has strategic partnerships with Merus N.V., GeneQuantum Healthcare (Suzhou) Co. Ltd., Aimed Bio, Inc., Yale University, Katholieke Universiteit Leuven, Bristol Meyers Squibb, and Hangzhou Highlightll Pharmaceutical Co. Ltd. Biohaven Ltd. was formerly known as Biohaven Research Ltd. and changed its name to Biohaven Ltd. in September 2022. Biohaven Ltd. was incorporated in 2022 and is headquartered in New Haven, Connecticut.

“Biohaven Pharmaceutical Holding Co Ltd Earnings” Can Refer to the Biohaven Pharmaceutical Holding Co Ltd Earnings Date

Some people say “Biohaven Pharmaceutical Holding Co Ltd earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Biohaven Pharmaceutical Holding Co Ltd position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Biohaven Pharmaceutical Holding Co Ltd Stock on the Earnings Date

If you own Biohaven Pharmaceutical Holding Co Ltd stock (BHVN) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Biohaven Pharmaceutical Holding Co Ltd might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Biohaven Pharmaceutical Holding Co Ltd shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Biohaven Pharmaceutical Holding Co Ltd Earnings

You can contact us any time if you would like to ask questions about Biohaven Pharmaceutical Holding Co Ltd earnings or anything else related to the stock market.